Paul M. Mendelman - Concepedia

Author

Paul M. Mendelman

Also Known As

Bargatze, Robert F., Goodwin, Robert R., P M Mendelman, P Mendelman, P. M. Mendelman, P. Mendelman, P.M. Mendelman, PAUL M. MENDELMAN, PAUL MENDELMAN, Paul M Mendelman

120

Publications

Citations

H-Index

101

Concepts

All Affiliations

University of Washington Takeda (United States)Baylor College of Medicine Takeda (Switzerland)Seattle Children's Hospital

About

Paul M. Mendelman is an author at University of Washington specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	39	2.7K
2	Health Sciences	12	14	707
3	Public Health	5	5	355
4	Allergy	2	2	242
5	Natural Sciences	1	1	17

Paul M. Mendelman

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children Robert B. Belshe, Paul M. Mendelman, John J. Treanor, New England Journal of Medicine	1998	918
Norovirus Vaccine against Experimental Human Norwalk Virus Illness Robert L. Atmar, David I. Bernstein, Clayton Harro, New England Journal of Medicine	2011	485
Reduction of Nasopharyngeal Carriage of Pneumococci during the Second Year of Life by a Heptavalent Conjugate Pneumococcal Vaccine R. Dagan, Rimma Melamed, M. Muallem, The Journal of Infectious Diseases	1996	480
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine Robert B. Belshe, William C. Gruber, Paul M. Mendelman, The Journal of Pediatrics VaccinationVaccine SafetyCross-protectionVaccine DevelopmentVirology	2000	430
Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus Vaccine Robert B. Belshe, William C. Gruber, Paul M. Mendelman, The Journal of Infectious Diseases	2000	412
Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults David I. Bernstein, Robert L. Atmar, G. Marshall Lyon, The Journal of Infectious Diseases	2014	274
Adjuvanted Intranasal Norwalk Virus‐Like Particle Vaccine Elicits Antibodies and Antibody‐Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues Samer S. El‐Kamary, Marcela F. Pasetti, Paul M. Mendelman, The Journal of Infectious Diseases	2010	221
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Paul M. Mendelman, Arnold L. Smith, Jack Lévy, PubMed Aminoglycoside PenetrationAntimicrobial ChemotherapyPulmonary PharmacologyInfection ControlAntimicrobial Resistance	1985	218
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae Paul M. Mendelman, Donald O. Chaffin, T L Stull, Antimicrobial Agents and Chemotherapy Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibioticsNon-beta-lactamase-mediated Ampicillin Resistance	1984	169
Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents Randy Bergen, Steve Black, Henry R. Shinefield, The Pediatric Infectious Disease Journal	2004	166

Page 1